Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-07-19Clinical Trial Update: Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 study of Onvansertib in combination with gemcitabine and nab-paclitaxel for locally advanced, unresectable, or metastatic pancreatic…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy [NA]
Results from a study evaluating the ExSpiron Respiratory Variation Monitor during upper GI endoscopy have been posted.
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: NALIRIFOX as Induction Therapy in LAPC [Phase 2]
Phase 2 trial update for NALIRIFOX induction therapy in locally advanced pancreatic cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline
This prospective registry of patients with resectable and borderline resectable pancreatic cancer has completed data collection.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer [Phase 2]
This update announces the completion and posting of results for a Phase 2 pilot study evaluating INNO-206 in advanced pancreatic ductal aden…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX [Phase 1, Phase 2]
The Phase 1/2 study of SLC-0111 in combination with gemcitabine for CAIX-positive metastatic pancreatic ductal adenocarcinoma has been termi…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery [Phase 3]
A Phase 3 trial evaluating ctDNA-guided treatment for localized pancreatic cancer, comparing neoadjuvant CTX chemotherapy to upfront surgery…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Peri-operative SLOG for Localized Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for peri-operative SLOG in localized pancreatic cancer (pancreatic ductal adenocarcinoma).
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma. [Phase 3]
Phase 3 clinical trial update for KN046 in advanced pancreatic ductal adenocarcinoma; status not specified.
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates [Phase 2]
A Phase 2 clinical trial evaluating perioperative therapy for resectable and borderline-resectable pancreatic adenocarcinoma with molecular …
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors [Phase 1, Phase 2]
Phase 1/2 first-in-human open-label dose-escalation study of a CSP-targeting functional antibody in solid tumors completed.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma [Phase 4]
A Phase 4 trial evaluating the synergistic immunomodulatory effect of synbiotics administered around surgical resection for pancreatic ducta…
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma [Phase 2, Phase 3]
Phase 2/3 trial update exploring S-1 combined with DC+CIK as maintenance therapy for advanced pancreatic ductal adenocarcinoma, status curre…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) [Phase 2]
Phase 2 trial of Paclitaxel Protein Bound with cisplatin, gemcitabine, and paricalcitol in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. [Phase 1]
Phase 1 trial evaluating safety and activity of 177Lu-3BP-227 in solid tumours expressing neurotensin receptor type 1; study terminated with…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
Phase 3 trial of relacorilant with nab-paclitaxel in metastatic pancreatic ductal adenocarcinoma was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 clinical trial investigating hyperpolarized 13C pyruvate MRI to assess treatment response in pancreatic ductal adenocarcinoma; statu…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Chlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial) [Phase 2]
Phase 2 clinical trial update evaluating chlorambucil in metastatic pancreatic ductal adenocarcinoma patients with germline DNA repair mutat…
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients [Phase 2]
Phase 2 clinical trial investigating sitagliptin combined with gemcitabine and albumin-bound paclitaxel in pancreatic ductal adenocarcinoma …
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation [Phase 2]
Phase 2 trial evaluating rucaparib in pancreatic cancer patients with a deleterious BRCA mutation has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial of ascorbic acid combined with nab-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 clinical trial update examining nab-paclitaxel plus gemcitabine in Korean patients with metastatic pancreatic ductal adenocarcinoma …
-
FDA approval · 2023-02-03FDA Approved: ONIVYDE — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
The FDA approved a supplemental application for ONIVYDE (liposomal irinotecan), submitted by Ipsen Biopharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating ultrasound-enhanced uptake of chemotherapy in patients with inoperable pancreatic ductal adenocarcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating BMS-813160 in combination with nivolumab, gemcitabine, and nab-paclitaxel in borderline resectable and l…